Related Experiment Videos
A transgenic mouse model for lung adenocarcinoma
A Sandmöller1, R Halter, G Suske
1Institut für Molekularbiologie und Tumorforschung, Philipps Universität, Marburg, Federal Republic of Germany.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|January 1, 1995
Summary
Researchers developed a transgenic mouse model to study lung cancer. This model, using Clara cell-specific expression of SV40 T antigen, enables in vivo and in vitro investigation of lung adenocarcinoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer remains a major cause of cancer-related mortality.
- Understanding lung tumor origins and progression requires robust models.
- Clara cells are key lung epithelial cells, and uteroglobin is their marker.
Purpose of the Study:
- To create a novel animal model for studying lung adenocarcinoma.
- To investigate the role of Clara cells in lung tumor development.
- To establish a cell line for in vitro lung cancer research.
Main Methods:
- Generation of transgenic mice expressing SV40 T antigen targeted to Clara cells via the uteroglobin promoter.
- Immunohistochemistry and in situ hybridization to analyze tumor stages.
- Establishment of a Clara cell line from transgenic mouse lungs.
Main Results:
- Transgenic mice developed multifocal bronchioloalveolar adenocarcinomas originating from Clara cells.
- Tumor progression showed distinct stages with differential expression of uteroglobin and SV40 T antigen.
- A stable Clara cell line retaining differentiated features was established.
Conclusions:
- The UT7.1 transgenic mouse line serves as a valuable model for lung adenocarcinoma research.
- This model facilitates the study of Clara cell-derived lung cancer in vivo and in vitro.
- The established cell line aids in understanding lung cancer development and progression.